Literature DB >> 16418183

Is glossectomy necessary for late nodal metastases without clinical local recurrence after initial brachytherapy for N0 tongue cancer? A retrospective experience in 111 patients who received salvage therapy for cervical failure.

Yusuke Urashima1, Katsumasa Nakamura, Naonobu Kunitake, Yoshiyuki Shioyama, Tomonari Sasaki, Saiji Ooga, Yuichiro Kuratomi, Tomoya Yamamoto, Toshiyuki Kawazu, Tooru Chikui, Kenichi Jingu, Hiromi Terashima, Hiroshi Honda.   

Abstract

PURPOSE: To assess the efficacy of neck dissection (ND) without glossectomy (GL) for late nodal metastases without local recurrence after brachytherapy for N0 tongue cancer.
MATERIALS AND METHODS: Among 396 patients with N0 tongue cancer treated with brachytherapy, a retrospective analysis was performed in 111 patients who were clinically diagnosed as having nodal metastases without local recurrence and whose neck lymph nodes turned out to be pathologically positive after salvage surgery. One hundred and five patients had undergone only ND (the ND group), six patients had undergone ND with GL (the ND+GL group).
RESULTS: The 5 year disease-free and cause-specific survival rates after salvage therapy for the 111 patients included in this study were 58.1 and 61.9%, respectively. In the ND group, there were only nine patients who had local recurrence after ND. In addition, only six patients (5.7%) had a local recurrence within 2 years in the ND group. Sixty-three patients were free of disease after ND, 31 patients had regional or distant metastases without local recurrence and two patients had progressive disease at ND. In the ND+GL group, four patients were alive without disease and two died from regional or distant metastases. None of the patients in the ND+GL group were found to have malignant tissue in the pathological findings from the excised tongue.
CONCLUSION: GL should be avoided or suspended when the clinical evaluation had revealed cervical failure without apparent local recurrence in the mobile tongue cancer patients after initial brachytherapy.

Entities:  

Mesh:

Year:  2006        PMID: 16418183     DOI: 10.1093/jjco/hyi218

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  3 in total

1.  Cesium implant for tongue carcinoma with a thickness of 1.5 cm or more: cases successfully treated with a Modified Manchester System.

Authors:  Takeshi Nishioka; Masaharu Fujino; Akihiro Homma; Tetsuro Yamashita; Akira Sato; Keiichi Ohmori; Kenichi Obinata; Hiroki Shirato; Kenichi Notani; Masamichi Nishio
Journal:  Yonsei Med J       Date:  2010-07       Impact factor: 2.759

2.  High-dose-rate interstitial brachytherapy in early stage oral tongue cancer - 15 year experience from a tertiary care institute.

Authors:  Anshuma Bansal; Sushmita Ghoshal; Arun S Oinam; Suresh Chander Sharma; Bhaswanth Dhanireddy; Rakesh Kapoor
Journal:  J Contemp Brachytherapy       Date:  2016-02-29

Review 3.  Post-glossectomy in lingual carcinomas: a scope for sign language in rehabilitation.

Authors:  Arvind Babu Rajendra Santosh; Keren Cumberbatch; Thaon Jones
Journal:  Contemp Oncol (Pozn)       Date:  2017-06-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.